Imedi (შპს იმედი)

panel 2026-09-21Ask

as filed · GEL, thousands

financial ratiosXLSX

Ratio	2018	2019	2020	2021	2022	2023	2024
Margins
Gross Margin	41.3%	60.4%	48.5%	60.1%	58.8%	63.5%	67.9%
EBITDA Margin	14.8%	22.3%	16.0%	8.5%	18.0%	25.3%	24.2%
EBITDAR	486	584	446	212	481	807	730
EBITDAR Margin	15.3%	23.6%	17.1%	9.9%	19.2%	26.3%	25.3%
EBIT Margin	10.5%	16.6%	11.0%	2.3%	12.9%	22.1%	18.5%
Net Profit Margin	7.1%	14.0%	9.6%	8.2%	10.7%	15.4%	9.0%
Operating Expense % of Sales	26.5%	38.0%	32.5%	51.6%	40.9%	38.2%	43.7%
Returns
Return on Assets (ROA)	14.2%	23.0%	15.4%	9.7%	15.0%	18.4%	12.6%
Return on Equity (ROE)	49.0%	65.9%	32.4%	19.2%	24.5%	84.4%	74.9%
ROIC [EBIT / Invested Capital]	23.9%	40.5%	28.1%	5.9%	59.9%	159.6%	40.9%
Leverage & debt balances
Debt-to-Assets	65.2%	55.0%	45.3%	40.0%	26.5%	72.7%	77.6%
Debt-to-Equity	2.25x	1.57x	0.95x	0.79x	0.43x	3.33x	4.63x
Debt-to-EBITDA	2.19x	1.49x	1.78x	3.94x	1.05x	2.39x	2.30x
Equity-to-Assets	29.0%	34.9%	47.5%	50.6%	61.2%	21.9%	16.8%
Net Debt	942	492	245	-77	-553	-134	964
Cash & Equivalents	95	333	495	794	1,025	1,993	643
Total Debt	1,037	825	740	717	473	1,859	1,607
Liquidity & working capital
Current Ratio	0.04x	0.01x	0.03x	0.04x	0.04x	0.08x	0.26x
Quick Ratio	0.04x	0.01x	0.00x	0.04x	0.04x	0.08x	0.26x
Cash Ratio	1.27x	5.16x	12.53x	8.81x	6.48x	26.28x	17.38x
Total Current Assets	3	1	1	4	7	6	10
Total Current Liabilities	74	65	40	90	158	76	37
Inventory	N/A	N/A	1	N/A	N/A	N/A	N/A
Trade Receivables	87	58	66	54	58	31	81
Trade Payables	74	65	38	90	158	76	37
Net Working Capital	-72	-64	-38	-87	-151	-70	-27
Net Working Capital % of Revenue	-2.3%	-2.6%	-1.5%	-4.0%	-6.0%	-2.3%	-0.9%
Trade Working Capital	13	-7	29	-36	-100	-45	44
Trade Working Capital % of Revenue	0.4%	-0.3%	1.1%	-1.7%	-4.0%	-1.5%	1.5%
Change in Trade Working Capital	N/A	-19	35	-65	-65	55	90
Turnover & efficiency
Inventory Turnover	N/A	N/A	1108.42x	N/A	N/A	N/A	N/A
Days Inventory Outstanding (DIO)	N/A	N/A	0.3	N/A	N/A	N/A	N/A
Receivables Turnover	36.56x	42.69x	39.72x	39.38x	43.51x	99.77x	35.52x
Days Sales Outstanding (DSO)	10.0	8.5	9.2	9.3	8.4	3.7	10.3
Payables Turnover	25.09x	15.20x	35.36x	9.47x	6.53x	14.74x	25.07x
Days Payable Outstanding (DPO)	14.5	24.0	10.3	38.5	55.9	24.8	14.6
Cash Conversion Cycle	-4.6 days	-15.5 days	-0.8 days	-29.3 days	-47.5 days	-21.1 days	-4.3 days
Asset Turnover	2.00x	1.65x	1.60x	1.19x	1.41x	1.20x	1.40x
Cash flow & dividends
Operating Cash Flow	-110	345	948	1,778	2,235	4,558	4,191
Free Cash Flow (OCF − Capex proxy)	-110	413	857	1,781	2,235	4,558	4,191
Cash Conversion (OCF / EBITDA)	-23.3%	62.5%	227.5%	977.3%	496.5%	586.7%	598.9%
Dividends Declared	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend Payout Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.

Imedi

Shareholders

Directors & board

Key statistics

About

Revenue & margins

Financial statements

Ownership & group structure

Shareholders

Directors & board

Peers